This is a maintenance therapy combination medicine in a dry powder form, pre-filled into capsules for use with a specific inhalation device. Each single-dose capsule contains a precise blend of:
Active Ingredients: Salmeterol (as Xinafoate) and Fluticasone Propionate IP.
Indicative Dose: The name ‘Mistovate-S 250’ and the “250 mcg” seen on the side of the bottle strongly imply a combined dose of 250 mcg, likely split as 50 mcg of Salmeterol and 200 mcg of Fluticasone Propionate per dose. Refer to the precise prescription details or inside pamphlet.
Mistovate®-S 250 is a maintenance treatment designed for the long-term control of symptoms of asthma and chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It pairs a long-acting bronchodilator (Salmeterol), which relaxes muscles in the airways to keep them open, with a powerful anti-inflammatory corticosteroid (Fluticasone Propionate), which reduces swelling and inflammation. This synergistic combination provides stable, 24-hour symptom control when used daily.
Pros:
Effective Maintenance: Provides reliable, around-the-clock control, significantly reducing the frequency and severity of asthma and COPD flare-ups.
Dual Synergistic Action: Combines anti-inflammatory and bronchodilator effects, addressing the two major underlying issues of chronic respiratory disease.
** stability:** Marketed as a stable and target formulation designed to provide comprehensive control.
Cons:
Not a Rescue Inhaler: Must not be used to treat sudden attacks of breathlessness. A separate, fast-acting “reliever” inhaler (like salbutamol) must still be carried at all times.
Prescription Required: Available only with a physician’s prescription and under strict medical supervision.
Potential for Side Effects: Common side effects can include a sore throat, headaches, muscle cramps, a high risk of mouth and throat infections (oral thrush), and, less frequently, increased heart rate. Rare, serious risks also exist, such as high blood pressure or increased cardiac effects.
Photosensitivity: Doxycycline can cause increased sensitivity to sunlight.
Consult Your Doctor: Strictly follow the exact dose, frequency (typically twice daily), and timing your physician has prescribed. Do not deviate.
Device Use: The capsules are for inhalation only and must not be swallowed. They must be used with the specific inhalation device provided.
Prevention of Side Effects: Immediately after each and every once-daily dose, rinse your mouth out thoroughly with water (do not swallow the water). This is a crucial step to prevent common infections in the mouth and throat.
Use with Caution: Requires careful use in patients with thyroid or kidney conditions.
Photosensitivity: Doxycycline can cause increased sensitivity to sunlight.
Mistovate®-S 250 is a prescription-only maintenance medication supplied in a carton containing a bottle of 30 specialized capsules and a dedicated inhalation device. Each single-use capsule contains a precise powder blend of the long-acting bronchodilator Salmeterol and the anti-inflammatory corticosteroid Fluticasone Propionate IP. It is indicated for the long-term, comprehensive control of persistent wheezing, shortness of breath, coughing, and chest tightness in patients with asthma and COPD, including chronic bronchitis and emphysema, by targeting both airway constriction and underlying inflammation. The product is marketed by Healthgate.
Healthgate is a leading respiratory pharma company in India, focused on delivering high-quality medicines for asthma, COPD, bronchitis, and other breathing disorders. With advanced formulations, strict quality standards, and a patient-centric approach, Healthgate ensures safe, effective, and affordable respiratory healthcare solutions across the nation through strong distribution support.
© 2025 Created with Hydra Infotech
This website uses cookies to provide you with the best browsing experience.